Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: